The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 26th 2024
Increased levels of absolute lymphocyte count are associated with improved response to BCMA-targeted CAR T-cell therapy.
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary Oncologists
February 27th 2024For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
Read More
FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer
February 26th 2024The sNDA was based on results from the KRYSTAL-1 study, evaluating the drug alone or in combination with other anti-cancer therapies in those with advanced solid tumors who have KRASG12C mutations.
Read More
Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Read More
FDA Accepts Priority Review for Linvoseltamab to Treat Adult Patients With R/R MM
February 22nd 2024Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.
Read More
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
Precision oncology represents an evolution in therapeutic practice.
Read More